GLP-1 receptor agonists work by: Enhancing insulin secretion from pancreatic beta cells in a glucose-dependent manner, which helps lower blood glucose levels without causing excessive hypoglycaemia Suppressing glucagon release from alpha cells, reducing hepatic glucose production Slowing gastric emptying , which prolongs the feeling of fullness after meals Acting on appetite centres in the brain , particularly the hypothalamus, to reduce hunger and food intake These medications are administered via subcutaneous injection, typically once weekly or once daily depending on the specific formulation
Baertling, F, Rodenburg, RJ, Schaper, J, Smeitink, JA, Koopman, WJH, Mayatepek, E, Morava, E, Distelmaier, F 2014, A guide to diagnosis and treatment of Leigh syndrome, Journal of Neurology, Neurosurgery & Psychiatry , vol
Originally developed for research purposes, SLU-PP-332 has shown remarkable potential in preclinical studies as a metabolic enhancer essentially mimicking the effects of physical exercise at the cellular level
Use a sterile syringe to inject bacteriostatic water slowly down the vial wall
Consult a health care professional before stopping or changing medication
Liz began working at St
